Drug policy in South Asia is based on a zero-tolerance approach with punitive legislation that leans heavily on incarceration for people involved in drug offences. Harm reduction and treatment services remain scarce and often of low quality. In the field of supply, crop eradication campaigns have been unable to curb opium production in the region.
Recent evidence suggests that allowing access to medical cannabis may reduce the frequency of opioid overdoses. This is particularly pertinent in India as certain regions have become increasingly gripped by a deadly opioid crisis.
75 countries met for the Brussels Conference on Afghanistan on the 4th and 5th October 2016, along with 26 international organisations and agencies. The Afghan government presented its plan for reform, which was endorsed by those countries attending, which pledged $15 billion toward maintaining…
This civil society letter led by IDPC requests ASEAN to establish opportunities for civil society organisations and affected communities to participate in the official process for the development of the new ASEAN strategy and work-plan on the use and supply of drugs.
The government will push to remove provisions of the country’s anti-narcotics law that require drug users to register with authorities and stipulates prison time for those who fail to do so, according to Colonel Zaw Win Tun of the Myanmar Police Force.
In this report, IDPC offers recommendations based on evidence and examples of good practice to inform a shift in policy responses to drug use in Asia away from criminalisation and punishment, and towards public health and harm reduction.